Epidemiology and treatment of multiple sclerosis in elderly populations
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epidemiology and treatment of multiple sclerosis in elderly populations
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-04-18
DOI
10.1038/s41582-019-0183-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis
- (2018) Sabina Luchetti et al. ACTA NEUROPATHOLOGICA
- Identification of Chronic Active Multiple Sclerosis Lesions on 3T MRI
- (2018) M. Absinta et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Deep gray matter volume loss drives disability worsening in multiple sclerosis
- (2018) Arman Eshaghi et al. ANNALS OF NEUROLOGY
- Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease
- (2018) Christina J. Azevedo et al. ANNALS OF NEUROLOGY
- Can we use regional grey matter atrophy sequence to stage neurodegeneration in multiple sclerosis?
- (2018) Bruno Stankoff et al. BRAIN
- Progression of regional grey matter atrophy in multiple sclerosis
- (2018) Arman Eshaghi et al. BRAIN
- Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis
- (2018) Michael G. Dwyer et al. JOURNAL OF NEUROIMAGING
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
- (2018) Raju Kapoor et al. LANCET NEUROLOGY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Preferential spinal cord volume loss in primary progressive multiple sclerosis
- (2018) Charidimos Tsagkas et al. Multiple Sclerosis Journal
- Discontinuation of disease-modifying therapy in patients with multiple sclerosis over age 60
- (2018) Le H Hua et al. Multiple Sclerosis Journal
- The current role of MRI in differentiating multiple sclerosis from its imaging mimics
- (2018) Ruth Geraldes et al. Nature Reviews Neurology
- Cerebral small vessel disease: from a focal to a global perspective
- (2018) Annemieke ter Telgte et al. Nature Reviews Neurology
- Multiple Sclerosis Mortality by Race/Ethnicity, Age, Sex, and Time Period in the United States, 1999–2015
- (2018) Lilyana Amezcua et al. NEUROEPIDEMIOLOGY
- Prospective associations between white matter hyperintensities and lower extremity function
- (2018) So Young Moon et al. NEUROLOGY
- Temporal trends in multiple sclerosis prevalence and incidence in a large population
- (2018) Dalia L. Rotstein et al. NEUROLOGY
- Spinal cord volume loss
- (2018) Charidimos Tsagkas et al. NEUROLOGY
- Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women
- (2018) Nils Koch-Henriksen et al. NEUROLOGY
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferential spinal cord volume loss in primary progressive multiple sclerosis
- (2018) Charidimos Tsagkas et al. Multiple Sclerosis Journal
- Discontinuation of disease-modifying therapy in patients with multiple sclerosis over age 60
- (2018) Le H Hua et al. Multiple Sclerosis Journal
- Common comorbidities and survival in MS: Risk for stroke, type 1 diabetes and infections
- (2018) A. Murtonen et al. Multiple Sclerosis and Related Disorders
- Preliminary investigation of cognitive function in aged multiple sclerosis patients: Challenges in detecting comorbid Alzheimer’s disease
- (2018) Shumita Roy et al. Multiple Sclerosis and Related Disorders
- Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
- (2018) Jerry S. Wolinsky et al. ANNALS OF NEUROLOGY
- Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study
- (2018) D. Jakimovski et al. EUROPEAN JOURNAL OF NEUROLOGY
- Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions
- (2018) Alessandra Musella et al. Frontiers in Aging Neuroscience
- Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial
- (2018) Edward J Fox et al. Multiple Sclerosis Journal
- Multiple Sclerosis Incidence and Prevalence Trends in the Province of Padua, Northeast Italy, 1965–2018
- (2018) Francesca Grassivaro et al. NEUROEPIDEMIOLOGY
- A Systematic Assessment of Prevalence, Incidence and Regional Distribution of Multiple Sclerosis in Bavaria From 2006 to 2015
- (2018) Tanja Daltrozzo et al. Frontiers in Neurology
- Chronic Infections: A Possible Scenario for Autophagy and Senescence Cross-Talk
- (2018) Milton Aguilera et al. Cells
- Evaluation of the Impact of Cognitive Training on Quality of Life in Patients with Multiple Sclerosis
- (2017) Maria Grazia Grasso et al. EUROPEAN NEUROLOGY
- Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging
- (2017) Ainhoa Plaza-Zabala et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume
- (2017) Daniel M. Harrison et al. JOURNAL OF NEUROIMAGING
- Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study
- (2017) Nils Koch-Henriksen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cerebellar lobule atrophy and disability in progressive MS
- (2017) Sirio Cocozza et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
- (2017) Hanne Marie Bøe Lunde et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – YES
- (2017) Ilya Kister Multiple Sclerosis Journal
- Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO
- (2017) W Oliver Tobin et al. Multiple Sclerosis Journal
- Age Related Multiple Sclerosis Severity Score: Disability ranked by age
- (2017) Ali Manouchehrinia et al. Multiple Sclerosis Journal
- Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
- (2017) Robert W Motl et al. Multiple Sclerosis Journal
- Senescent cells: an emerging target for diseases of ageing
- (2017) Bennett G. Childs et al. NATURE REVIEWS DRUG DISCOVERY
- Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
- (2017) Paolo A. Muraro et al. Nature Reviews Neurology
- Autologous hematopoietic stem cell transplantation in multiple sclerosis
- (2017) Maria Pia Sormani et al. NEUROLOGY
- Wellness and the Role of Comorbidities in Multiple Sclerosis
- (2017) Brandon P. Moss et al. Neurotherapeutics
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reliability, precision, and clinically important change of the Nine-Hole Peg Test in individuals with multiple sclerosis
- (2017) Mario Hervault et al. INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH
- Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis
- (2017) Jonathan Zurawski et al. JAMA Neurology
- Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
- (2017) Paolo A. Muraro et al. JAMA Neurology
- Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – YES
- (2017) Ilya Kister Multiple Sclerosis Journal
- Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO
- (2017) W Oliver Tobin et al. Multiple Sclerosis Journal
- Age Related Multiple Sclerosis Severity Score: Disability ranked by age
- (2017) Ali Manouchehrinia et al. Multiple Sclerosis Journal
- Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
- (2017) Robert W Motl et al. Multiple Sclerosis Journal
- Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses
- (2017) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model
- (2017) Bert A. ’t Hart et al. Frontiers in Immunology
- Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments
- (2017) Ann Marie Weideman et al. Frontiers in Neurology
- The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
- (2016) Lukas Haider et al. BRAIN
- Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine
- (2016) Robert Zivadinov et al. Expert Review of Neurotherapeutics
- Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis
- (2016) Amandine Moroso et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
- (2016) Ilya Kister et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- B2 Cell-based assays of CAG repeat instability in the huntingtin (HTT) gene
- (2016) Tom Massey et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study
- (2016) Laure Peyro Saint Paul et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Differential effects of aging on motor and cognitive functioning in multiple sclerosis
- (2016) Shumita Roy et al. Multiple Sclerosis Journal
- Aging and multiple sclerosis
- (2016) Shaik Ahmed Sanai et al. Multiple Sclerosis Journal
- Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study
- (2016) Robert Zivadinov et al. Multiple Sclerosis Journal
- Advanced MRI and staging of multiple sclerosis lesions
- (2016) Martina Absinta et al. Nature Reviews Neurology
- The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
- (2016) Pascal Sati et al. Nature Reviews Neurology
- Multiple sclerosis prevalence in the United States commercially insured population
- (2016) Piyameth Dilokthornsakul et al. NEUROLOGY
- Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis
- (2016) Tingting Zhang et al. NEUROLOGY
- Systematic, Evidence-Based Review of Exercise, Physical Activity, and Physical Fitness Effects on Cognition in Persons with Multiple Sclerosis
- (2016) Brian M. Sandroff et al. NEUROPSYCHOLOGY REVIEW
- Exercise training effects on memory and hippocampal viscoelasticity in multiple sclerosis: a novel application of magnetic resonance elastography
- (2016) Brian M. Sandroff et al. NEURORADIOLOGY
- Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study
- (2016) Robert Zivadinov et al. RADIOLOGY
- Cardiovascular Risk Factors Associated with Smaller Brain Volumes in Regions Identified as Early Predictors of Cognitive Decline
- (2016) Rajiv N. Srinivasa et al. RADIOLOGY
- Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine
- (2016) Robert Zivadinov et al. Expert Review of Neurotherapeutics
- Differential effects of aging on motor and cognitive functioning in multiple sclerosis
- (2016) Shumita Roy et al. Multiple Sclerosis Journal
- Aging and multiple sclerosis
- (2016) Shaik Ahmed Sanai et al. Multiple Sclerosis Journal
- Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study
- (2016) Robert Zivadinov et al. Multiple Sclerosis Journal
- Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades
- (2015) N. Grytten et al. ACTA NEUROLOGICA SCANDINAVICA
- Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
- (2015) Josa M. Frischer et al. ANNALS OF NEUROLOGY
- Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis
- (2015) Khaled Abdel-Aziz et al. BRAIN
- Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant
- (2015) Martijn D. Steenwijk et al. BRAIN
- Multiple Sclerosis Mortality Rates in Canada, 1975-2009
- (2015) Sharon A. Warren et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios
- (2015) Ali Manouchehrinia et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Role of the innate and adaptive immune responses in the course of multiple sclerosis
- (2015) Bernhard Hemmer et al. LANCET NEUROLOGY
- The changing face of multiple sclerosis: Prevalence and incidence in an aging population
- (2015) C Solaro et al. Multiple Sclerosis Journal
- A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
- (2015) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Spinal cord MRI in multiple sclerosis—diagnostic, prognostic and clinical value
- (2015) Hugh Kearney et al. Nature Reviews Neurology
- Exploring the origins of grey matter damage in multiple sclerosis
- (2015) Massimiliano Calabrese et al. NATURE REVIEWS NEUROSCIENCE
- Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment
- (2015) Afsaneh Shirani et al. Biomed Research International
- Effect of Smoking Cessation on Multiple Sclerosis Prognosis
- (2015) Ryan Ramanujam et al. JAMA Neurology
- Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis
- (2015) Regina Schlaeger et al. JAMA Neurology
- The changing face of multiple sclerosis: Prevalence and incidence in an aging population
- (2015) C Solaro et al. Multiple Sclerosis Journal
- A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
- (2015) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease
- (2015) Josiane Budni et al. Aging and Disease
- An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis
- (2015) Neeta Garg et al. Brain and Behavior
- Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database
- (2015) Gorana Capkun et al. Multiple Sclerosis and Related Disorders
- Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics
- (2014) Oscar G. Vidaurre et al. BRAIN
- Relapsing and progressive forms of multiple sclerosis
- (2014) Ranjan Dutta et al. CURRENT OPINION IN NEUROLOGY
- Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice
- (2014) Massimiliano Cristofanilli et al. EXPERIMENTAL NEUROLOGY
- Vascular comorbidities in the onset and progression of multiple sclerosis
- (2014) Prudence Tettey et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Aaron E Miller et al. LANCET NEUROLOGY
- Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Christian Confavreux et al. LANCET NEUROLOGY
- Iron in multiple sclerosis: roles in neurodegeneration and repair
- (2014) Erin Stephenson et al. Nature Reviews Neurology
- The Increasing Prevalence of Multiple Sclerosis in New Zealand
- (2014) Sridhar Alla et al. NEUROEPIDEMIOLOGY
- Relapses and disability accumulation in progressive multiple sclerosis
- (2014) M. M. Paz Soldan et al. NEUROLOGY
- Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study
- (2013) Ali Manouchehrinia et al. BRAIN
- The Immune Pathogenesis of Multiple Sclerosis
- (2013) Robert Weissert Journal of Neuroimmune Pharmacology
- Onset of secondary progressive phase and long-term evolution of multiple sclerosis
- (2013) A. Scalfari et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pathology and disease mechanisms in different stages of multiple sclerosis
- (2013) Hans Lassmann JOURNAL OF THE NEUROLOGICAL SCIENCES
- High risk of cardiovascular diseases after diagnosis of multiple sclerosis
- (2013) Elham Jadidi et al. Multiple Sclerosis Journal
- Mortality in patients with multiple sclerosis
- (2013) A. Scalfari et al. NEUROLOGY
- Imaging Cortical Damage and Dysfunction in Multiple Sclerosis
- (2013) Massimo Filippi et al. JAMA Neurology
- Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S.
- (2013) D.W. Kaufman et al. Multiple Sclerosis and Related Disorders
- Cortical lesion load associates with progression of disability in multiple sclerosis
- (2012) M. Calabrese et al. BRAIN
- Inflamm-ageing
- (2012) Elisa Cevenini et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study
- (2012) Virginia Devonshire et al. LANCET NEUROLOGY
- Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia
- (2012) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis
- (2012) M. Tutuncu et al. Multiple Sclerosis Journal
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Is Donepezil Effective for Multiple Sclerosis-related Cognitive Dysfunction?
- (2012) Cumara B. O’Carroll et al. NEUROLOGIST
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla
- (2011) F. Bagnato et al. BRAIN
- Factors influencing healthy aging with multiple sclerosis: a qualitative study
- (2011) Michelle Ploughman et al. DISABILITY AND REHABILITATION
- Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis
- (2011) M. B. D’hooghe et al. EUROPEAN JOURNAL OF NEUROLOGY
- Human brain changes across the life span: A review of 56 longitudinal magnetic resonance imaging studies
- (2011) Anna M. Hedman et al. HUMAN BRAIN MAPPING
- Treatment of multiple sclerosis: current concepts and future perspectives
- (2011) Dorothea Buck et al. JOURNAL OF NEUROLOGY
- Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada
- (2011) E Kingwell et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cognitive Functioning in Multiple Sclerosis
- (2011) Laura J. Julian NEUROLOGIC CLINICS
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- The diagnostic criteria for multiple sclerosis: From Charcot to McDonald
- (2011) Arie Gafson et al. Multiple Sclerosis and Related Disorders
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2010) J. M. Fletcher et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Mortality in multiple sclerosis: a review
- (2010) P. Ragonese et al. EUROPEAN JOURNAL OF NEUROLOGY
- Comorbidities amongst patients with multiple sclerosis: a population-based controlled study
- (2010) J.-H. Kang et al. EUROPEAN JOURNAL OF NEUROLOGY
- Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009
- (2010) S. Simpson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cognitive reserve moderates decline in information processing speed in multiple sclerosis patients
- (2010) RALPH H.B. BENEDICT et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- The changing demographic pattern of multiple sclerosis epidemiology
- (2010) Nils Koch-Henriksen et al. LANCET NEUROLOGY
- Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy
- (2010) Robert A Bermel et al. Multiple Sclerosis Journal
- Risk of Arterial Cardiovascular Diseases in Patients with Multiple Sclerosis: A Population-Based Cohort Study
- (2010) Christian Fynbo Christiansen et al. NEUROEPIDEMIOLOGY
- Analysis of current multiple sclerosis registries
- (2010) B. J. Hurwitz NEUROLOGY
- Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis
- (2010) R. A. Marrie et al. NEUROLOGY
- The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
- (2010) R. A. Marrie et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cognitive Aging in Patients with Multiple Sclerosis: A Cross-Sectional Analysis of Speeded Processing
- (2009) A. M. Bodling et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis
- (2009) Mehrdad Alirezaei et al. Autophagy
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Cognitive reserve protects against cognitive dysfunction in multiple sclerosis
- (2009) James F. Sumowski et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Role of the innate immune system in the pathogenesis of multiple sclerosis
- (2009) Roopali Gandhi et al. JOURNAL OF NEUROIMMUNOLOGY
- Multiple sclerosis immunology: The healthy immune system vs the MS immune system
- (2009) L. H. Kasper et al. NEUROLOGY
- Gray matter atrophy in multiple sclerosis: A longitudinal study
- (2008) Elizabeth Fisher et al. ANNALS OF NEUROLOGY
- Gray matter atrophy is related to long-term disability in multiple sclerosis
- (2008) Leonora K. Fisniku et al. ANNALS OF NEUROLOGY
- Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron
- (2008) Kathryn E. Hammond et al. ANNALS OF NEUROLOGY
- Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement
- (2008) Machteld M. Vellinga et al. BRAIN
- Survival and cause of death in multiple sclerosis: a prospective population-based study
- (2008) C Hirst et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Relapses in multiple sclerosis are age- and time-dependent
- (2008) H Tremlett et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Taking ageing into account in remyelination-based therapies for multiple sclerosis
- (2008) Julia M. Rist et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Memantine induces reversible neurologic impairment in patients with MS
- (2008) P. Villoslada et al. NEUROLOGY
- Comorbidity delays diagnosis and increases disability at diagnosis in MS
- (2008) R. A. Marrie et al. NEUROLOGY
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started